Sterimax
As of the edition of 20 October 2026, Sterimax runs 11 drugs, 11 of them marketed; it is on route A at 0 targets and on route B at 10 targets.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 11 |
| Total | 11 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Testosterone | none listed | 4 |
| Norepinephrine | none listed | 19 |
| Hydralazine | none listed | 1 |
| Dihydroergotamine | none listed | 1 |
| Cefotaxime | none listed | 0 |
| Orphenadrine | none listed | 2 |
| Streptomycin | none listed | 0 |
| Cloxacillin | none listed | 0 |
| Testosterone propionate | none listed | 1 |
| Ergoloid | none listed | 13 |
| Triamcinolone diacetate | none listed | 1 |
A route B row is one company at one target.
Where it needs a new molecule
Route A at 0 targets, route B at 10 targets.
All 10 rows on route A or B
In the product10 company-target rows on route A or B; 7 are not shown here, and no score is.
See all 10 targets where Sterimax needs a new molecule, with the facts behind eachRequest access. Nothing is shown until you do.